F. Wiberg

发表

New, small circular DNA in transfected mammalian cells

P. Sunnerhagen, G. Bjursell, F. Wiberg, 1986, Molecular and cellular biology.

Interactions of a hybrid insulin/insulin-like growth factor-I analog with chimeric insulin/type I insulin-like growth factor receptors.

R. Mirmira, L. Schäffer, A. S. Andersen, 1993, The Journal of biological chemistry.

Characterization of the allosteric binding pocket of human liver fructose‐1,6‐bisphosphatase by protein crystallography and inhibitor activity studies

L. Thim, S. Hastrup, J. Kastrup, 1997, Protein science : a publication of the Protein Society.

Changing the insulin receptor to possess insulin-like growth factor I ligand specificity.

N. Møłler, K. Norris, A. S. Andersen, 1990, Biochemistry.

Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency.

H. Klein, B. Hansen, G. Danielsen, 1996, The Biochemical journal.

Expression and Characterization of a 70-kDa Fragment of the Insulin Receptor That Binds Insulin

L. Schäffer, A. S. Andersen, C. Kristensen, 1998, The Journal of Biological Chemistry.

The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site.

N. Møłler, N. Møller, L. Schäffer, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Discovery and structure-activity relationship of the first non-peptide competitive human glucagon receptor antagonists.

R. Carr, L. B. Knudsen, P. Madsen, 1998, Journal of medicinal chemistry.

Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.

K. Norris, F. Norris, A. Pedersen, 1990, The Journal of biological chemistry.

Characterization of recombinant human HBP/CAP37/azurocidin, a pleiotropic mediator of inflammation‐enhancing LPS‐induced cytokine release from monocytes

L. Thim, S. Hastrup, P. F. Nielsen, 1996, FEBS letters.

Identification of determinants that confer ligand specificity on the insulin receptor.

N. Møłler, L. Schäffer, P. De Meyts, 1992, The Journal of biological chemistry.

Specificity of Insulin and Insulin-like Growth Factor I Receptors Investigated using Chimeric Mini-Receptors

A. S. Andersen, C. Kristensen, F. Wiberg, 1999, The Journal of Biological Chemistry.

Immobilized insulin for high capacity affinity chromatography of insulin receptors.

L. Schäffer, J. Markussen, F. Wiberg, 1991, The Journal of biological chemistry.

A single-chain insulin-like growth factor I/insulin hybrid binds with high affinity to the insulin receptor.

L. Schäffer, A. S. Andersen, C. Kristensen, 1995, The Biochemical journal.

Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: evidence for its role in factor VII-tissue factor interaction.

J. Birktoft, L. Petersen, D. Foster, 1993, Biochemistry.

Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine.

W. Kisiel, L. Thim, Y. Komiyama, 1991, The Journal of biological chemistry.

Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog

Sven Branner, Finn C. Wiberg, S. Branner, 2003, Nature Structural Biology.

Alanine Scanning Mutagenesis of Insulin*

Claus Kristensen, Svend Havelund, D. Steiner, 1997, The Journal of Biological Chemistry.

Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity

J. Holst, C. Deacon, L. B. Knudsen, 1998, Diabetologia.

Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic use

Henrik Næsted, Cecilia Förberg, A. Tolstrup, 2011, Biotechnology and bioengineering.

Efficient transient and stable expression in mammalian cells of transfected genes using erythrocyte ghost fusion.

P. Sunnerhagen, G. Bjursell, F. Wiberg, 1987, Experimental cell research.

Replication and expression in mammalian cells of transfected DNA; description of an improved erythrocyte ghost fusion technique.

J. Zeuthen, P. Sunnerhagen, G. Bjursell, 1983, Nucleic acids research.

Structure and function of the N‐linked glycans of HBP/CAP37/azurocidin: Crystal structure determination and biological characterization of nonglycosylated HBP

J. Kastrup, L. Iversen, P. Rasmussen, 1999, Protein science : a publication of the Protein Society.

Expression, purification, crystallization and crystallographic characterization of dimeric and monomeric human neutrophil gelatinase associated lipocalin (NGAL).

R. Strong, J. Cowland, N. Borregaard, 1998, Acta crystallographica. Section D, Biological crystallography.

Selective Down-regulation of the Insulin Receptor Signal by Protein-tyrosine Phosphatases α and ε (*)

A. Ullrich, R. Lammers, N. Møller, 1995, The Journal of Biological Chemistry.

Structure of HBP, a multifunctional protein with a serine proteinase fold

J. Kastrup, L. Iversen, P. Rasmussen, 1997, Nature Structural Biology.

Chimeric receptors indicate that phenylalanine 39 is a major contributor to insulin specificity of the insulin receptor.

A. S. Andersen, T. Kjeldsen, F. Wiberg, 1994, The Journal of biological chemistry.

Production of target‐specific recombinant human polyclonal antibodies in mammalian cells

A. Tolstrup, J. Sharon, T. P. Frandsen, 2006, Biotechnology and bioengineering.

Localization of Specific Amino Acids Contributing to Insulin Specificity of the Insulin Receptor

A. S. Andersen, F. Wiberg, Thomas Kjeldsen, 1995, Annals of the New York Academy of Sciences.

Discovery and structure-activity relationship of the first non-peptide competitive human glucagon receptor antagonists.

L. B. Knudsen, F. Wiberg, Peter Madsen, 1998, Journal of medicinal chemistry.